BTF3 affects hepatocellular carcinoma progression by transcriptionally upregulating PDCD2L and inactivating p53 signaling
Abstract Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, with the characteristics of high mortality and low 5-year survival rate. The potential role of BTF3 and PDCD2L in HCC remains unclear. Our study found that BTF3 expression was upregulated in hepatocellular carcinoma...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-12-01
|
| Col·lecció: | Molecular Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s10020-024-01044-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|